The Rare Diseases Clinical Research Network is an NIH-funded research network of 20 active consortia or research groups working to advance treatment for diseases that are rare. Use the search tools on this page to find the diseases we currently study. You can reach out to the indicated consortia or research groups for more information on those diseases and studies underway.
This network focuses on clinical research and does not generally support clinical care outside of research activities. To learn about other rare diseases, please visit the Genetic and Rare Diseases Information Center (GARD), which is an NIH program that helps the public find reliable information about rare and genetic diseases. Their staff are specialists. Contact them at 1-888-205-2311 or email GARDinfo@nih.gov.
All Diseases > N-Acetylglutamate Synthase Deficiency
N-Acetylglutamate Synthase Deficiency (NAGS)
Disease Category: Urea Cycle Disorders
An inherited, metabolic, urea cycle disorder characterized by hyperammonemia (high blood ammonia levels) due to deficiency or absence of an enzyme needed to convert nitrogen from protein metabolism (break down) into urea (a waste product). Symptoms include vomiting, feeding and growth problems, fatigue, seizures, respiratory distress, abnormal movements, coma, ataxia (lack of coordination), confusion, developmental delay, and intellectual disability.
Research groups studying this disease
Urea Cycle Disorders
Urea Cycle Disorders Consortium (UCDC)View Disease Definition
Long-term observation of the impact of UCDs on physical and neurological functioning, the relationship between health indicators and disease severity and the eﬃciency of UCD therapies.
5111: Orphan Europe Carbaglu® Surveillance Protocol In Collaboration with the Longitudinal Study of Urea Cycle Disorders
A post-marketing surveillance of carglumic acid (Carbaglu) to obtain long-term clinical safety information. Carglumic acid was approved by the United States Food and Drug Administration (FDA) for treatment of acute hyperammonemia due to N-acetylglutamate synthase (NAGS) deﬁciency.
Study of how UCDs aﬀect thinking, body chemistry and brain structure using magnetic resonance imaging (MRI) and behavioral testing.
The purpose of this research is to determine if silent seizures (electrographic seizures) occur during a hyperammonemic (HA) episode in patients with urea cycle disorders (UCD). Urea cycle disorders lead to accumulation increased ammonia due to problems breaking down protein. The symptoms of UCD may present at birth, childhood or adulthood (milder deficiencies) and are associated with cognitive deficits, changes in behavior, brain swelling and seizures. Sometime the seizures are not clinically obvious, but can be picked up if a video recording and concurrent EEG (video EEG is used, cVEEG). cVEEG is used in many intensive care units across the country to pick up seizures. We want to determine if having seizures due to HA leads to any adverse cognitive outcomes, and want to use the EEG to identify any changes that may be associated with that.
5121: Neurodevelopmental Assessments in the Longitudinal Study of Urea Cycle Disorders: Comparison of Standard (Traditional) Neuropsychological Battery and NIH Toolbox
We are doing this study to see how the results of two sets of tools used to measure developmental progress relate to one another and how acceptable completing each of these measures is to children and families of children with Urea Cycle Disorders. We are anxious to make longitudinal assessment (repeated observations over time) of cognition easier, quicker and more accessible for families of children with urea cycle disorders. In order to do so we want to understand the relationship between the 2 sets of measures.